The World Health Organization has suspended the approval of tuberculosis drugs from India's Svizera Labs, according to a Reuters article. This decision comes following an investigation into quality standards.
The agency reportedly said it put a hold on all TB products made at Svizera's Mumbai site because manufacturing standards and quality management were unreliable. Read the full story
